Clinical trial
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously…
NCT00470366 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00470366 |
|---|---|
| Title | Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors |
| Official title | Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Previously Untreated Intermediate and Poor Risk Germ Cell Tumor Patients |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer, Teratoma, Testicular Germ Cell Tumor |
| Intervention type | Biological, Drug |
| Interventions | pegfilgrastim, cisplatin, ifosfamide, paclitaxel |
| Enrollment | 60 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2016 |
| Completion | Jun 1, 2016 |
| First posted | May 7, 2007 |
| Last update posted | Nov 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: